The Patient Journey in Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD): Results From Cross-sectional Patient and Physician Surveys
infection, intracranial hypotension, and vasculitis (p=0.035).Diffuse involvement was more likely to be smooth, and focal (less than 50% of the entire brain circumference) more likely to be nodular (p=0.35). ConclusionsTo our knowledge, this is the largest single-center study of HP with biopsy results.Imaging features can be suggestive of underlying diagnoses, many of which are inflammatory.
Authors
- Emily Trenholm (ORCID: https://orcid.org/0009-0003-1737-3698)
- Sofia Zappacosta
- Friedemann Paul (ORCID: https://orcid.org/0000-0002-6378-0070)
- Silvia Narduzzi (ORCID: https://orcid.org/0000-0003-2539-9583)
- Michaël Levy (ORCID: https://orcid.org/0000-0003-2766-5777)
- Meheni Khellaf (ORCID: https://orcid.org/0000-0002-6449-5917)
- Mia Unsworth
Publication Details
- Journal
- Neurology
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1212/01.wnl.0001051416.97564.fa
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Sanofi
- Alexion Pharmaceuticals
- Celgene
- Aarhus Universitet
- Mitsubishi Tanabe Pharma Corporation
- Genentech
- Sanofi Genzyme
- Medical Research Council
- UCB Pharma